BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241225T080000
DTEND;TZID=Europe/Brussels:20241227T200000
DTSTAMP:20260808T003658
CREATED:20241113T103614Z
LAST-MODIFIED:20241113T103616Z
UID:8467-1735113600-1735329600@www.europabio.org
SUMMARY:2nd ESAB Digital Congress
DESCRIPTION:After the successful first digital ESAB Congress last year\, the Scientific Committee has decided that a digital ESAB congress will take place again this year from November 25-27. \n\n\n\nDeadline for abstract submission: 31 October 2024 \n\n\n\nESAB Aims \n\n\n\n\nto take initiatives in areas of growing scientific and industrial interest and importance in the field of applied biocatalysis\n\n\n\n\n\nto identify key topics which may be rate-limiting in the development of scientific progress and technological prospects in applied biocatalysis and to take steps to stimulate these areas\n\n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/2nd-esab-digital-congress/
CATEGORIES:Biomanufacturing Platform,External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/11/Event-Banner-E-Congress-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241210T080000
DTEND;TZID=Europe/Brussels:20241211T200000
DTSTAMP:20260808T003658
CREATED:20240531T115038Z
LAST-MODIFIED:20240603T072409Z
UID:7883-1733817600-1733947200@www.europabio.org
SUMMARY:The European Bioplastics Conference 2024
DESCRIPTION:We are happy to announce that the EBC 24 will take place on 10/11 December 2024 at the Titanic Hotel Berlin\, Germany.    \n\n\n\nThe European Bioplastics Conference is Europe’s leading business and discussion forum within the global bioplastics sector. More and more brands and manufacturers are embracing the potential of biopolymers\, and policy makers are increasingly streamlining their efforts to create frameworks that benefit the growth of sustainable bio-industries. Now is the time to put bioplastics at the top of the agenda of a biobased circular economy in Europe and beyond. \n\n\n\nThe registration for the EBC 24 is now open and we are excited to welcome you on 10/11 December 2024 in Berlin or online. \n\n\n\nThe hybrid format of this year’s event will again allow you to join either in person at the Titanic Hotel Berlin or comfortably log-in from your home base. Both of which offer unique networking opportunities. \n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/the-european-bioplastics-conference-2024/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/05/External-Events-Banners-600-×-200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241122T140000
DTEND;TZID=Europe/Brussels:20241122T160000
DTSTAMP:20260808T003658
CREATED:20241125T083939Z
LAST-MODIFIED:20241125T083942Z
UID:8482-1732284000-1732291200@www.europabio.org
SUMMARY:What's Next for Biotech & Biosecurity: EU & US Post Election Landscape
DESCRIPTION:Join our Healthcare Public Affairs Director\, Vlad Olteanu on Friday 22nd November to listen to What’s next for Biotech and Biosecurity in the EU & US post elections.  \n\n\n\n\nMore information & Registerion Here
URL:https://www.europabio.org/event/whats-next-for-biotech-biosecurity-eu-us-post-election-landscape/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/11/External-Events-Banners-600-×-200px-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241119T080000
DTEND;TZID=Europe/Brussels:20241119T200000
DTSTAMP:20260808T003658
CREATED:20240619T110353Z
LAST-MODIFIED:20240619T110641Z
UID:7976-1732003200-1732046400@www.europabio.org
SUMMARY:AseBio Green Innovation Forum
DESCRIPTION:Organized by AseBio\, the Spanish Bioindustry Association\, and Sodena the financial agent of the Government of Navarra\, the 5th edition of the AseBio Green Innovation Forum will be held in the Baluarte convention centerof Pamplona on November 19\, 2024. The event will showcase the opportunities that biotechnology can offer as a key tool in the transition towards a more sustainable\, carbon neutral and greener economic model.  The Green Innovation Forum is also firmly committed to achieving the objectives set out in the 2030 Agenda and the European Green Deal. The AseBio Green Innovation Forum will have an agenda of round tables and business meetings in which to address the most relevant aspects of innovation in biotechnology and the green economy. We will also seek to find solutions to medium-long term challenges such as climate change\, industrial transformation\, sustainable food\, or the development of bio-products\, among others. RegistrationRegistration for the Green Innovation Forum 24 is now open. Take advantage of the early bird rates until July 31st. \n\n\n\nPresent your companyCompanies that are members of AseBio or domiciled in Navarra can submit a proposal to present their company before an audience of specialized investors and companies at no extra cost of your registration fee. Sinx-minute presentations will be delivered onsite on November 19th\, 2024. Not all applications will be accepted. A selection committee will review and accept or decline all applications. The deadline to apply: is September 20\, 2024 \n\n\n\nIf you wish to become a member of AseBio please visit our website. \n\n\n\nSponsorship opportunities \n\n\n\nDo you wish to become a sponsor of the Green Innovation Forum? \n\n\n\nGreeen Innovation Forum 2024 will provide you with a unique opportunity to meet face-to-face within Spanish and international  cutting edge companies and research institutions in the green biotech space. \n\n\n\nSponsoring the event will help to create interest in your company\, products and services and also: \n\n\n\n\nRaise your profile within the Spanish and European biotech industry.\n\n\n\n\n\nOther benefits\, as included in the different sponsorship packages.\n\n\n\n\n\n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/asebio-green-innovation-forum/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/06/External-Events-Banners-600-×-200px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241112T090000
DTEND;TZID=Europe/Brussels:20241112T123000
DTSTAMP:20260808T003658
CREATED:20241029T085347Z
LAST-MODIFIED:20241029T085348Z
UID:8437-1731402000-1731414600@www.europabio.org
SUMMARY:Advancing bio-based innovations in the food industry: Focus on fermentation
DESCRIPTION:Join our Director General Dr Claire Skentelbery on the 12th of November in Brussels where she will be speaking at the DG GROW hosted hybrid workshop “Advancing bio-based innovations in the food industry: Focus on fermentation”. \n\n\n\nThe workshop will focus on the industrial applications of fermentation technologies by highlighting SMEs that are using biomass\, precision and gas fermentation. Their innovative technologies will be presented\, along with ways to promote scaling up production. These presentations will be followed by a Q&A session. \n\n\n\nAfter these industry insights\, a panel of experts will discuss topics such as research and innovation\, infrastructure\, the role of farmers\, public acceptance\, market development\, and profitability and pricing. In addition to the fermentation types presented at the beginning of the workshop\, micro fermentation will be discussed. \n\n\n\nDeadline for registrations: 4 November 2024 \n\n\n\n\nMore Information & Register Here
URL:https://www.europabio.org/event/advancing-bio-based-innovations-in-the-food-industry-focus-on-fermentation/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/10/External-Events-Banners-600-×-200px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241104T080000
DTEND;TZID=Europe/Brussels:20241106T200000
DTSTAMP:20260808T003658
CREATED:20241009T073025Z
LAST-MODIFIED:20241009T074047Z
UID:8389-1730707200-1730923200@www.europabio.org
SUMMARY:BIO-Europe® 2024
DESCRIPTION:BIO-Europe® 2024 – 30th Annual International Partnering Conference  \n\n\n\nDates:November 4-6\, 2024 | Stockholm\, SwedenNovember 12–13\, 2024 | Digital PartneringVenue: Stockholmsmässan \n\n\n\nVenue address: Mässvägen 1\, 125 80 Stockholm Sweden \n\n\n\nJoin the 30th anniversary edition of BIO-Europe\, the biopharma partnering event that has grown with the industry\, innovated alongside it\, and remains the gathering place for meaningful and memorable conversations and connections. In 2023\, BIO-Europe reached new levels of attendance\, engagement\, and collaboration. 2024 promises to deliver quality opportunities for connection and partnering. The 30th annual BIO-Europe will take place November 4-6\, 2024 in Stockholm\, Sweden\, and it will convene over 5\,500 life science professionals representing more than 2\,800 companies from over 60 countries. Attendees will take part in 29\,000 one-to-one meetings over the course of the event. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/bio-europe-2024/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2024/10/External-Events-Banners-600-×-200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241023T080000
DTEND;TZID=Europe/Brussels:20241024T200000
DTSTAMP:20260808T003658
CREATED:20241003T082016Z
LAST-MODIFIED:20241003T082123Z
UID:8368-1729670400-1729800000@www.europabio.org
SUMMARY:Regulating the Future of Food Conference
DESCRIPTION:Join our Industrial Biotechnology Senior Manager Lucie McMurtry on the 23rd and 24th of October in Amsterdam where she will be speaking at the Regulating the Future of Food Conference. \n\n\n\nGlobal innovation in food-tech is growing at an incredible pace and there are so many amazing new products and processes out there! This innovation is vital in making a difference to the planet by creating more sustainable and ‘greener’ food systems\, whilst also contributing to economic growth. \n\n\n\nRegulators are doing their best to keep up. They are all working on ways to evolve in line with innovation and create more effective and efficient ways to regulate novel foods\, whilst keeping safety as the key priority. However\, regulations are often seen as a barrier to innovation due to complex frameworks\, a lack of clear guidance and long evaluation timelines. \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/regulating-the-future-of-food-conference/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/10/Healthcare-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241022T080000
DTEND;TZID=Europe/Brussels:20241025T170000
DTSTAMP:20260808T003658
CREATED:20240611T071159Z
LAST-MODIFIED:20240611T071200Z
UID:7930-1729584000-1729875600@www.europabio.org
SUMMARY:World Orphan Drug Congress Europe 2024
DESCRIPTION:The World Orphan Drug Congress Europe is the largest and most established orphan drug & rare disease event worldwide. Meet over 2000 attendees\, hear from 250 leading speakers\, and connect with 130 exhibitors as we bring together experts from the start-to-finish of orphan drugs. From regulation and policy to global pricing and gene therapy\, the Congress has it covered. \n\n\n\nOur attendees include the most senior individuals across the industry\, including; R&D\, Gene Therapy and Rare diseases\, Precision/Personalised Medicine\, Genetic Disorders\, Patient Advocacy and Engagement\, Associations in ATMPs\, Investors\, Regulatory Affairs Professionals\, Governmental Bodies and many more … \n\n\n\nUse code “EUBIO20” to save an additional 20% off the Pharma/Biotech and Standard packages.
URL:https://www.europabio.org/event/world-orphan-drug-congress-europe-2024/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/06/Event-Website-Banner-EBIO-WODC-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241008T100000
DTEND;TZID=Europe/Brussels:20241010T180000
DTSTAMP:20260808T003658
CREATED:20240828T135105Z
LAST-MODIFIED:20240828T135930Z
UID:8158-1728381600-1728583200@www.europabio.org
SUMMARY:CPHI Milan
DESCRIPTION:EuropaBio is pleased to partner with CPHI Milan 2024\, the biggest international pharmaceutical industry event for the thirty fifth anniversary edition. This year’s edition held from the 8th to the 10th of October in Fiera Milano\, Italy promises to a packed agenda with over 150 expert international speakers with over 100 content sessions. \n\n\n\nJoin our Director General Dr Claire Skentelbery this year where she will be speaking on the 9th of October to discuss how cultivated meat has the potential to revolutionise biologic manufacturing. Join her in Hall 3 – 3F97 at 16:15 on 09/10/2024 to find out more. \n\n\n\n \n\n\n\n\nFind Out More & Register Here
URL:https://www.europabio.org/event/cphi-milan/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/08/CPHI-x-EuropaBio-2024-Event-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20241002T170000
DTEND;TZID=Europe/Brussels:20241002T193000
DTSTAMP:20260808T003658
CREATED:20240827T080153Z
LAST-MODIFIED:20240827T080535Z
UID:8151-1727888400-1727897400@www.europabio.org
SUMMARY:Enhancing Europe's Pharma and Biotech Competitiveness and Open Strategic Autonomy
DESCRIPTION:Join our Director General Dr Claire Skentelbery on 2 October 2024 where she will be speaking at the Novartis & BritCham event “Enhancing Europe’s Pharma and Biotech Competitiveness and Open Strategic Autonomy”. \n\n\n\n\nFind Out More & Register Here
URL:https://www.europabio.org/event/enhancing-europes-pharma-and-biotech-competitiveness-and-open-strategic-autonomy/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/08/BritCham-Novartis-Event-Banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240710T080000
DTEND;TZID=Europe/Brussels:20240711T170000
DTSTAMP:20260808T003658
CREATED:20240531T135225Z
LAST-MODIFIED:20240531T135227Z
UID:7893-1720598400-1720717200@www.europabio.org
SUMMARY:CURIOUS­ FUTURE INSIGHT™ CONFERENCE
DESCRIPTION:Over the millennia science & technology have steadily advanced\, but key unsolved challenges remain\, and much more is possible. The Curious – Future Insight™ Conference brings together some of the world’s brightest scientists and most accomplished innovators to present their work and explore the future of science and technology\, solving the challenges of today and enabling the dreams of a better tomorrow. \n\n\n\nThe Curious – Future Insight™ conference featurestop speakers and Nobel laureates from all over theworld\, among them: \n\n\n\n\nEmmanuelle Charpentier\, MPI (2018)\n\n\n\nSteven Chu\, Stanford University (2024)\n\n\n\nRobert Langer\, MIT (2024)\n\n\n\nSatya Nadella\, CEO Microsoft (2018)\n\n\n\nUğur Şahin\, CEO BioNTech (2024)\n\n\n\nRandy Schekman\, Berkeley (2024)\n\n\n\nThomas C. Südhof\, Stanford University (2024\, 2022)\n\n\n\nCraig Venter\, Craig Venter Institute (2018)
URL:https://www.europabio.org/event/curious-future-insight-conference/
CATEGORIES:Biomanufacturing Platform,External,Healthcare Biotech,Industrial Biotech,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/05/Curious-Insights-Banner-600-×-200px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240613T113000
DTEND;TZID=Europe/Brussels:20240613T130000
DTSTAMP:20260808T003658
CREATED:20240513T142126Z
LAST-MODIFIED:20240513T142128Z
UID:7789-1718278200-1718283600@www.europabio.org
SUMMARY:Industrial Biotechnology Day (2nd edition) - Biotechnology as key enabling technology for EU Strategies and Ambitions
DESCRIPTION:Explore how industrial biotechnologies can achieve Europe’s environmental ambitions. Discussions will centre on exploring both regulatory frameworks and technological advancements\, identifying our core strengths and opportunities\, and pinpointing areas for improvement. From evaluating feedstocks and industrial capabilities to overcoming regulatory challenges\, join us in shaping a sustainable path forward for the European chemical industry through biotech innovations. \n\n\n\nThis session is organised by Cefic Sector Groups: EFCG\, EFG and Biochem Europe; EuropaBio and SICOS. \n\n\n\n\nClick here for more information
URL:https://www.europabio.org/event/industrial-biotechnology-day-2nd-edition-biotechnology-as-key-enabling-technology-for-eu-strategies-and-ambitions/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/05/Healthcare-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240516T090000
DTEND;TZID=Europe/Brussels:20240516T180000
DTSTAMP:20260808T003658
CREATED:20240118T152254Z
LAST-MODIFIED:20240118T152720Z
UID:7279-1715850000-1715882400@www.europabio.org
SUMMARY:Knowledge for Growth
DESCRIPTION:Get ready for the touchdown of Europe’s finest life sciences conference\, Knowledge for Growth\, on May 16\, 2024\, in the vibrant city of Antwerp\, Belgium!Elevate your network by rubbing shoulders with decision-makers from biotech\, pharma\, and MedTech\, alongside investors\, universities\, cutting-edge research institutes\, policymakers\, and competence providers. Join over 1000 life sciences trailblazers representing 500+ companies & organizations! Uncover the future with our riveting programme\, delivering key insights into the global and regional life sciences landscape. Engage in dynamic B2B partnering\, explore groundbreaking innovations at the trade fair\, and seize endless networking opportunities.Ready to be part of the life sciences revolution? Secure your spot now here! #KnowledgeForGrowth #KFG2024  \n\n\n\n\nClick here for more information
URL:https://www.europabio.org/event/knowledge-for-growth-2/
LOCATION:Flanders Meeting & Convention Center Antwerp
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/01/Event-Banners-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240514T200000
DTEND;TZID=Europe/Brussels:20240515T180000
DTSTAMP:20260808T003658
CREATED:20240311T142703Z
LAST-MODIFIED:20240311T142744Z
UID:7536-1715716800-1715796000@www.europabio.org
SUMMARY:AseBio Investor Day
DESCRIPTION:We are thrilled to announce that AseBio will hold the fifth edition of the AseBio Investor Day at the gorgeous Kursaal conference center in San Sebastián (Spain) on the 15th of May. The AseBio Investor Day is a forum that aims to connect the Spanish biotechnology industry with national and international investors. \n\n\n\nSince its first edition (Barcelona\, 2017)\, the event has attracted national and international investors\, contributing to give visibility to the national biotechnology industry. AseBio Investor Day also fosters networking between investors from Spain and the rest of the world. \n\n\n\nAseBio Investor Day includes a program of round tables where relevant topics on investment and finance will be addressed\, one-to-one meetings and startup pitch presentations. There will also be socials where you can meet your peers and biotech entrepreneurs. \n\n\n\nMeeting Spanish biotechnology is an opportunity to access new deal flow opportunities. Spain is the 9th largest originator of knowledge in biotechnology by number of papers. As of 2023 there were about 900 firms fully dedicated to biotechnology and 270 firms partially dedicated to biotechnology. In 2022 the sector attracted €142 million. \n\n\n\nIn our last edition more than 260 attendees participated in Investor Day and more than 330 one-to-one meetings were held through our matchmaking tool. \n\n\n\nSan Sebastián is a beautiful coastal town in the Spanish Basque Country. The city boasts stunning beaches\, a rich gastronomical tradition with one to the highest densities of Michelin star restaurants in the world\, splendid architecture and a thriving cultural life. The event will take place immediately after BioEquity\, which this year will be held on May 14 and May 15 in the same venue. \n\n\n\nIf you are planning to attend BioEquity why not extend your stay one more day and join us for an opportunity to meet Spanish biotechnology. Investors are cordially invited to participate in the AseBio Investor Day 2024. \n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/asebio-investor-day/
LOCATION:Kursaal Zurriola Hiribidea\, 1 20002 Donostia\, Guipuzkoa (Spain)
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/03/Healthcare.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240416T083000
DTEND;TZID=Europe/Brussels:20240416T120000
DTSTAMP:20260808T003658
CREATED:20240326T082922Z
LAST-MODIFIED:20240326T083218Z
UID:7614-1713256200-1713268800@www.europabio.org
SUMMARY:RARE DISEASES FORUM 2024
DESCRIPTION:Against the backdrop of the Belgian EU Council Presidency\, the Rare Diseases Forum 2024 brings together senior leaders from across patient organisations\, industry and policy to address how and why innovation in tackling rare diseases can support the EU’s competitiveness agenda. \n\n\n\n \n\n\n\nAbout ‘The Rare Diseases Forum 2024: Securing Europe’s Competitiveness in R&D for people living with rare diseases’ features keynotes and panel discussions with a focus on the EU’s role in enhancing competitiveness in life sciences\, fostering investment in the rare diseases sector\, and examining the benefits of a competitive agenda for those with rare diseases.  \n\n\n\nThe event is convened by Global Counsel on behalf of the forum partners\, EURORDIS\, RaDiOrg\, EFPIA\, Eucope\, EuropaBio\, Pharma.be\, UCB\, Novo Nordisk\, Sanofi & Takeda.
URL:https://www.europabio.org/event/rare-diseases-forum-2024/
CATEGORIES:EuropaBio,External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/03/Event-Banner-Website-updated.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240229T090000
DTEND;TZID=Europe/Brussels:20240301T170000
DTSTAMP:20260808T003658
CREATED:20240214T085311Z
LAST-MODIFIED:20240214T100345Z
UID:7415-1709197200-1709312400@www.europabio.org
SUMMARY:International Congress on Rare Diseases and Orphan Drugs 2024
DESCRIPTION:Navigating the Uncharted: Advancements\, Collaborations\, and Hope in Rare Diseases \n\n\n\nSupported by EuropaBio \n\n\n\n \n\n\n\nAbout the event: \n\n\n\nEmbrace the extraordinary journey into the world of rare diseases at our groundbreaking International Congress\, where innovation\, collaboration\, and hope converge! \n\n\n\nThe International Congress on Rare Diseases and Orphan Drugs is organized by Rare Diseases Greece (RDG)\, member of EURORDIS-Rare Diseases Europe and Boussias Events. \n\n\n\nFollowing the success of the previous years and having advanced the policy agenda on both a national and international level\, the Organizing Committee – consisting of Rare Diseases Greece (RDG)\, the 30-member umbrella organization that represents the country’s rare disease community\, brings together all the key initiatives and stakeholders currently shaping the rare disease landscape with the aim to set a course for the future of rare diseases. \n\n\n\nAttendance details: \n\n\n\nThursday\, 29.02.2024 (Hybrid | Technopolis City of Athens Gasholder 1 – Auditorium “Miltiadis Evert”) & Friday\, 01.03.2024 (Digital) \n\n\n\n \n\n\n\n\nRegister here\n\n\n\n\n \n\n\n\n\nFind out more here
URL:https://www.europabio.org/event/international-congress-on-rare-diseases-and-orphan-drugs-2024/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/02/Event-Banner-International-Congress-on-Rare-Diseases-Orphan-Drugs-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240214T080000
DTEND;TZID=Europe/Brussels:20240214T170000
DTSTAMP:20260808T003658
CREATED:20240130T125205Z
LAST-MODIFIED:20240130T125207Z
UID:7333-1707897600-1707930000@www.europabio.org
SUMMARY:Europe Rare Disease Summit 2024
DESCRIPTION:How to improve and learn about Government Plans\, Access & Financing\, Clinical Research and Innovation\, Artificial Intelligence and Data\, and Social & Patient. \n\n\n\nJoin our very own Healthcare Policy Senior Manager\, Adrien Samson in Madrid where he will be speaking in the panel “Innovation\, Funding and Access to Orphan Drugs: Challenges and Opportunities” between 12:15 and 13:00. \n\n\n\n \n\n\n\nWe are thrilled to announce the eagerly awaited second edition of the Europe Rare Disease Summit\, set to take place in February. Joining forces from all corners of Europe\, this prestigious event brings together leading researchers\, healthcare professionals\, patient advocates\, policymakers\, industry experts\, and rare disease patients and families. \n\n\n\nThe summit emphasizes the power of collaboration and solidarity in facing rare diseases. Together\, we can accelerate research\, enhance patient care\, and improve outcomes\, offering a brighter future for those affected by rare diseases. \n\n\n\nKey Objectives: \n\n\n\nEmpowering Patients: Putting patients at the heart of our efforts\, we strive to enhance their access to quality care and support\, while advocating for their rights and unique challenges. \n\n\n\nAdvancing Research: Renowned scientists will present groundbreaking discoveries\, fostering cross-disciplinary collaboration to propel rare disease research forward. \n\n\n\nBuilding Collaborative Networks: A platform for stakeholders to connect\, exchange ideas\, and form strategic partnerships\, bridging gaps in research\, treatment\, and support. \n\n\n\nInfluencing Policy: By engaging policymakers\, we seek to drive positive changes and better support the rare disease community. \n\n\n\nEngaging Program Highlights: Expect a dynamic lineup of keynote speeches\, interactive workshops\, panel discussions and networking opportunities. Share experiences\, learn from experts\, and inspire change. \n\n\n\nLocation and Dates: Prepare to be inspired in the vibrant setting of Madrid on February 14th. \n\n\n\nWho will Attend: \n\n\n\nRare Disease AdvocatesResearchers and ScientistsHealthcare ProfessionalsIndustry LeadersPolicymakers and Government RepresentativesPharmaceutical and Biotech CompaniesInvestors and Venture CapitalistsAcademics and Students
URL:https://www.europabio.org/event/europe-rare-disease-summit-2024/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/01/Event-Banner-ERDS-2024.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20240124T120000
DTEND;TZID=Europe/Brussels:20240124T150000
DTSTAMP:20260808T003658
CREATED:20240109T104014Z
LAST-MODIFIED:20240116T095205Z
UID:7234-1706097600-1706108400@www.europabio.org
SUMMARY:EU pharmaceutical legislation - Europe’s biotech innovation in the balance?
DESCRIPTION:Event agenda \n\n\n\n12:00: Registration opens \n\n\n\n12:30: Panel starts \n\n\n\n13:45: Panel close and networking lunch \n\n\n\n15:00: Close \n\n\n\nConfirmed Speakers \n\n\n\nTomislav Sokol MEPMember SANT Committee\, European Parliament \n\n\n\nHilde StevensCo-director\, Institute for Interdisciplinary Innovation in Healthcare (I3H)\, ULB \n\n\n\nKristin ThompsonChief Operating Officer\, eureKARE \n\n\n\nVivian TsevelekiChief Operating Officer\, theraCell \n\n\n\nMore to be announced soon \n\n\n\nIntroduction \n\n\n\nIn April 2023\, the European Commission adopted a proposal for a new Directive and a new Regulation\, aimed at revising and replacing the existing General Pharmaceutical Legislation (GPL). The proposal focuses on modernising the pharmaceutical sector with a patient-centred approach\, while also fully supporting an innovative and competitive industry. \n\n\n\nThrough the proposal\, the EU aims to offer an attractive and innovation-friendly environment for research\, development\, and production of medicines in Europe. The EU plans to create this environment by promoting world-class innovation\, governed by stable and consistent rules that keep pace with innovation and which increase competitiveness while reducing red tape and costs. \n\n\n\nOne of the sectors impacted by the proposal is that of biotechnology\, which has been instrumental in the discovery and development of therapies\, diagnostics\, vaccines and\, most importantly\, advanced medicines. These ‘next generation medicines’ are delivered through a complex and interdependent biotechnology ecosystem\, where companies of all sizes contribute to establishing a pathway to patients. \n\n\n\nJoin this Euractiv Hybrid Conference to discuss Europe’s biotech innovation in light of the EU’s reform of the General Pharmaceutical Legislation.  \n\n\n\nQuestions to be discussed include: \n\n\n\n\nHow can Europe’s biotechnology industry maintain its competitiveness in the global medical market?\n\n\n\nHow can we establish a framework that fosters the growth of small biotech innovators?\n\n\n\nWhat are the reactions of investors to the challenges faced by small biotech companies\, and how do these reactions influence the trajectory of innovation in the biotech industry?\n\n\n\nWhat strategies can be employed to establish a successful innovation pathway for biotech companies\, while considering and aligning with the objectives of the reformed GPL?
URL:https://www.europabio.org/event/eu-pharmaceutical-legislation-europes-biotech-innovation-in-the-balance/
CATEGORIES:All,EuropaBio,External,Healthcare Biotech,SME Platform
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2024/01/EuropaBio.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20231106T153000
DTEND;TZID=Europe/Brussels:20231106T163000
DTSTAMP:20260808T003658
CREATED:20231013T105949Z
LAST-MODIFIED:20231013T105951Z
UID:6985-1699284600-1699288200@www.europabio.org
SUMMARY:BIO Europe 2023
DESCRIPTION:The European Pharmaceutical Legislation – Will it keep the light on for biotech in Europe? \n\n\n\nJoin our Director General\, Dr. Claire Skentelbery on the 6th of November in Munich for her panel discussing what the legislation brings\, its potential impact on businesses and what needs to be done to change the legislation in its journey to a final version\, that it works for both\, the biotech ecosystem\, maintaining innovation pipelines\, and patients.
URL:https://www.europabio.org/event/bio-europe-2023/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/10/Screenshot-2023-10-13-113155.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20231101T080000
DTEND;TZID=Europe/Brussels:20231102T170000
DTSTAMP:20260808T003658
CREATED:20231013T082312Z
LAST-MODIFIED:20231013T082314Z
UID:6977-1698825600-1698944400@www.europabio.org
SUMMARY:World Orphan Drug Congress
DESCRIPTION:The World Orphan Drug Congress is the largest and most established orphan drugs & rare diseases meeting of its kind across the globe. \n\n\n\nJoin our Director General\, Dr. Claire Skentelbery on the 1st of November for her Keynote Panel: How to navigate the new legislation to enable orphan drug developers to stay innovative and profitable in Europe. \n\n\n\nAs well as on the 2nd on November for her Panel: How to enable SME’s to obtain greater market access.
URL:https://www.europabio.org/event/world-orphan-drug-congress/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/10/Screenshot-2023-10-13-101414.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20231023T124000
DTEND;TZID=Europe/Brussels:20231023T141000
DTSTAMP:20260808T003658
CREATED:20231012T114428Z
LAST-MODIFIED:20231012T115640Z
UID:6973-1698064800-1698070200@www.europabio.org
SUMMARY:TOPRA Symposium 2023: advancing global healthcare together
DESCRIPTION:Session: Update on EU new regulatory legislation and a view from different angles \n\n\n\nJoin our very own Valentin Plouchard who will be speaking at the TOPRA Annual Symposium in Lisbon on the 23rd of October.
URL:https://www.europabio.org/event/topra-symposium-2023-advancing-global-healthcare-together/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/10/Screenshot-2023-10-12-133359.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20231011T133000
DTEND;TZID=Europe/Brussels:20231011T150000
DTSTAMP:20260808T003658
CREATED:20230920T110911Z
LAST-MODIFIED:20230920T110912Z
UID:6861-1697031000-1697036400@www.europabio.org
SUMMARY:SMEs in a Changing World: The Impact of the Revision of the Pharmaceutical Legislation on Europe’s innovative SMEs
DESCRIPTION:In April 2023\, the European Commission published new legislative proposals to revise the EU’s long-standing pharmaceutical legislation and ensure it can meet the challenges of the 21st century. The revision will redefine the regulatory framework for medicines and have a significant impact on the global innovation ecosystem. \n\n\n\nAs emerging and small companies have become innovation drivers\, responsible for over two-thirds of the R&D pipeline that will become the medicines of tomorrow\, changing the rule book that has helped build Europe’s small company ecosystem over the last 20 years is going to have consequences for start-ups\, emerging and small companies looking to first enter the market but also on mid-size companies looking for growth opportunities in Europe. \n\n\n\nThis event will be an opportunity to highlight the role of small and mid-size companies in developing medicines for patients\, assess the foreseeable impacts of the revision on those companies\, and hear directly from them what they need from the revision to continue their journey in Europe.
URL:https://www.europabio.org/event/smes-in-a-changing-world-the-impact-of-the-revision-of-the-pharmaceutical-legislation-on-europes-innovative-smes/
CATEGORIES:EuropaBio,External,Healthcare Biotech,SME Platform
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/09/Event-Banners-Website.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230929T100000
DTEND;TZID=Europe/Brussels:20230930T190000
DTSTAMP:20260808T003658
CREATED:20230320T153927Z
LAST-MODIFIED:20230320T160626Z
UID:6049-1695981600-1696100400@www.europabio.org
SUMMARY:International Forum on Industrial Biotechnology and Bioeconomy (IFIB)
DESCRIPTION:NETWORKING AND PARTNERSHIPS IN BIOECONOMY AREA \n\n\n\nIFIB – International Forum on Industrial Biotechnology and Bioeconomy aims at strengthening the bioeconomy network in the Euro-Mediterranean area and to promote partnerships. The focus of the Forum is biotechnology\, as provider of new resources for industries. \n\n\n\nIt is organized into round-tables and sessions devoted to specific sub-sectors of industrial biotechnology: bio-based industries\, agro-food\, energy\, environment policies on industrial biotech and bioeconomy\, involving international speakers coming from key sector’s players. \n\n\n\nEdition 2023 > 29/30 September Bari \n\n\n\n\nMore information
URL:https://www.europabio.org/event/international-forum-on-industrial-biotechnology-and-bioeconomy-ifib/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/03/Event-Page-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230926T100000
DTEND;TZID=Europe/Brussels:20230928T190000
DTSTAMP:20260808T003658
CREATED:20230320T145053Z
LAST-MODIFIED:20230320T145327Z
UID:6038-1695722400-1695927600@www.europabio.org
SUMMARY:BIOSPAIN 2023
DESCRIPTION:BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 34% of our delegates came from outside of Spain. \n\n\n\nThis year\, BIOSPAIN goes back to Barcelona\, the main biotech cluster in Spain and one of the most dynamic cities in the world. \n\n\n\nThe event will take place in Pavilion 1 – Fira de Barcelona – Montjuïc. It stands in a superb location in the city center\, easily accessible from the airport and well-connected to the public transport network. It is located in Montjuïc Park\, an area of cultural and historical interest thanks to its museums and theatres and it also features some of the main tourist attractions in Barcelona. \n\n\n\n\nMore information
URL:https://www.europabio.org/event/biospain-2023/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/03/Event-Page-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230920T080000
DTEND;TZID=Europe/Brussels:20230921T170000
DTSTAMP:20260808T003658
CREATED:20230615T070358Z
LAST-MODIFIED:20230615T070523Z
UID:6387-1695196800-1695315600@www.europabio.org
SUMMARY:Life Sciences Baltics as a contributor to Lithuania’s innovation ecosystem
DESCRIPTION:Life sciences in Lithuania have been a priority for the government for over a decade. Accelerating faster than almost anywhere else in Europe\, the sector aims to contribute 5% to Lithuania’s GDP by 2030. The close cooperation between actors of the ecosystem is one of the reason for success.   \n\n\n\nCreative collaboration takes place in Lithuania’s innovation ecosystem in a variety of ways\, including events\, cross-promotion\, and sharing of resources. The leading life sciences Baltics event in the region – Life Sciences Baltics – is one of the best examples of these collaborations. \n\n\n\nSince its initiation in 2012\, the forum has aimed to create as many opportunities as it is possible for deeper cooperation between the growing life sciences ecosystems in the Baltics and international partners. \n\n\n\nHeld every two years\, the forum has grown from a 300-person assembly to a community of up to 800 key participants from around 40 countries: corporate CEOs\, startup founders\, tech scouts\, investors\, researchers. It is the largest life sciences event in the Eastern and Central Europe. \n\n\n\nThe event will take place in the Lithuania’s capital city of Vilnius on September 20-21. The pre-registration is already open for participants and exhibitors. \n\n\n\nWhether there is a need to kick off the project\, generate leads\, or engage in valuable partnerships\, Life Sciences Baltics offers a diverse range of interactions for its participants: international conference\, exhibition\, networking spaces\, pitch challenge for startups. \n\n\n\nIt also hosts business delegations and offers an opportunity for side visits to Lithuania’s organizations and institutions. \n\n\n\nThe program of the international conference is divided into sessions with the most trending topics worldwide that are also breakthrough areas in the Baltic countries: gene editing\, CRISPR diagnostics\, AI and digital health innovations\, nanomedicine\, microbiome\, reinvention of clinical trials\, digital biomarkers and many more. \n\n\n\nMany big names have attended Life Sciences Baltics\, among them Thermo Fisher Baltics\, Johnson&Johnson\, Clarivate\, Novartis\, Abbvie\, AstraZeneca\, and others. Nobel prize winners Richard Henderson\, Brian Kobilka\, Dan Shechtman\, CRISPR pioneer Prof. Dr Virginijus Šikšnys were among top conference speakers. \n\n\n\nThe event will keep tabs on the fastest growing startups in the region\, but only 10 hand-picked startups will have an opportunity to showcase who they are in front of a panel of investors. \n\n\n\nThe event is organized by Innovation Agency Lithuania\, an official public agency responsible for the Lithuanian innovation ecosystem and is supported by Lithuania’s local ecosystem actors – Lithuanian biotechnology association\, universities\, hospitals\, business angels and Lithuania’s life sciences enthusiasts.  \n\n\n\nThe Baltics\, and Lithuania in particular\, – the next big thing in life sciences  \n\n\n\nLife Sciences Baltics make it possible to assess the attractiveness of the Baltic countries in close-up – Estonia\, Latvia and Lithuania show their distinct\, but strong potential in the sector. \n\n\n\nThree Baltic countries are particularly seeing a growth in life sciences startups. While average funding per startup is decreasing globally\, it’s increasing in the region.  Lithuania attracts growing VC interest into global solutions produced by local entrepreneurs and scientists. \n\n\n\nFocused on nurturing the next generation of talents\, the local life sciences enterprises in the Baltics excel at creativity and entrepreneurship. In 2021 alone\, Lithuania’s life sciences sector grew by almost 87% and generated revenues of 2 billion euros. \n\n\n\n90% of the output of Lithuania’s life sciences are exported to more than 100 countries worldwide. Lithuanian-made medical and pharmaceutical equipment and other products are trusted by customers in the USA\, Germany\, France\, and elsewhere. \n\n\n\nOne of the most prominent players in Lithuania is Thermo Fisher Scientific Baltics\, which has stimulated the development of Lithuania’s industry during the last decade. This company\, along with other international players in the market\, work with local actors for various R&D projects and supply chain. \n\n\n\n\nFor more details
URL:https://www.europabio.org/event/life-sciences-baltics-as-a-contributor-to-lithuanias-innovation-ecosystem/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/06/Event-Banners-Website-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230704T100000
DTEND;TZID=Europe/Brussels:20230704T170000
DTSTAMP:20260808T003658
CREATED:20230614T151559Z
LAST-MODIFIED:20230614T151749Z
UID:6377-1688464800-1688490000@www.europabio.org
SUMMARY:Industrial Biotechnologies Day
DESCRIPTION:CEFIC Specialty Chemicals sector groups EFCG\, Biochem Europe and EFG\, together with SICOS\, the French industry association for Fine Chemicals and Biotech\, will jointly hold their first in-person Industrial Biotechnologies Day on July 4th\, 2023 in Brussels. \n\n\n\nSpecialists from the industry\, EU policy makers\, and civil society will come together across four panels to dive into topics such as: \n\n\n\n\nEuropean policies shaping the biotech landscape – what is needed to unleash its full potential?\n\n\n\nEuropean regulatory frameworks – an obstacle to innovation?\n\n\n\nFeedstocks and industrial capacities – what is the role of energy costs?\n\n\n\nNew technologies and future breakthroughs – what to expect and what’s at stake?\n\n\n\n\nConfirmed Speakers: \n\n\n\n\nHans Ingels\, European Commission – Directorate-General for Internal Market\, Industry\, Entrepreneurship and SMEs\n\n\n\nLudo Diels\, Flemish Institute for Technological Research (VITO)\n\n\n\nVincent Touraille\, Sicos\n\n\n\nKarel De Winter\, Bio Base Europe Pilot Plant\n\n\n\nMarcello Buson\, Olon SpA\n\n\n\nFrédéric Van Gansberghe\, Futerro\n\n\n\nClaire Skentelberry\, Europabio\n\n\n\nChristian Le Roux\, Group M21\n\n\n\nHarald Ruissenaars\, Corbion\n\n\n\nEric Bierny\, Galactic\n\n\n\nNicolas Martin\, Metex\n\n\n\nThomas Canova\, Solvay\n\n\n\nJulien Honoré\, Roquette\n\n\n\nJuliette Martin\, Seqens\n\n\n\nGwenaël Servant\, Abolis\n\n\n\n\n\nMore details
URL:https://www.europabio.org/event/industrial-biotechnologies-day/
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/06/Event-Banners-Website.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230630T124500
DTEND;TZID=Europe/Brussels:20230630T124500
DTSTAMP:20260808T003658
CREATED:20230321T210403Z
LAST-MODIFIED:20230321T210405Z
UID:6074-1688129100-1688129100@www.europabio.org
SUMMARY:DUTCH BIOTECH EVENT 2023
DESCRIPTION:Join us to celebrate the power of biotech at the Dutch Biotech Event 2023! \n\n\n\nAbout HollandBIO’s Dutch Biotech Event \n\n\n\nThe program features inspiring talks by keynote speakers on biotech and entrepreneurship\, followed by workshops and break-out sessions that contribute to your personal development and that of your company. In addition\, there will be plenty of opportunities for networking during the break\, drinks and vegetarian BBQ. \n\n\n\nWho can join Dutch Biotech Event? \n\n\n\nThe Dutch Biotech Event welcomes HollandBIO members (registration free of charge) and employees of other biotech R&D companies (registration fee €295\,- p.p.)\, with a maximum of 2 delegates per organization. \n\n\n\nWe invite non-member startups to consider a HollandBIO membership (€562\,-/year)\, which besides access to the network & events\, offers many more advantages. \n\n\n\n\nMore information
URL:https://www.europabio.org/event/dutch-biotech-event-2023/
LOCATION:Inn Style\, Herenweg 55\, Maarssen\, 3602 AN\, Netherlands
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2023/03/Event-Page-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230627T140000
DTEND;TZID=Europe/Brussels:20230627T160000
DTSTAMP:20260808T003658
CREATED:20230516T093527Z
LAST-MODIFIED:20230517T184028Z
UID:6244-1687874400-1687881600@www.europabio.org
SUMMARY:Reflection seminar and closing party around the EU presidency
DESCRIPTION:On June 27\, a Life Science conference is arranged for EU parliamentarians during Sweden’s EU presidency. \n\n\n\nDirectly after the official conference\, The Royal Academy of Engineering Sciences (IVA) and SwedenBIO invites the public to a seminar with the spotlight on how the suggested EU legislations may affect the life science industry. With examples from the Swedish life science arena\, we show the importance of intellectual property and data protection in the journey from academic research to products and therapies for patients. \n\n\n\nAfterward\, a networking reception is organized by the united life science industry organisations. With drinks\, snacks\, and key speakers\, we ensure that the end of the presidency marks the start of an even stronger united life science industry in Sweden and beyond. \n\n\n\n\nMore details
URL:https://www.europabio.org/event/reflection-seminar-and-closing-party-around-the-eu-presidency/
LOCATION:IVA Conference Center\, Grev Turegatan 15\, Stockholm\, Sweden
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/05/External-Events-Banners.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230616T083000
DTEND;TZID=Europe/Brussels:20230616T100000
DTSTAMP:20260808T003658
CREATED:20230524T085454Z
LAST-MODIFIED:20230524T142847Z
UID:6326-1686904200-1686909600@www.europabio.org
SUMMARY:GREEK BIOPHARMA INNOVATION: Your changing world with the new EU Pharma Legislation
DESCRIPTION:Chairperson: Claire Skentelbery\, Director General EuropaBio \n\n\n\nParticipants: \n\n\n\nKostas Papagiannis Country President & Managing Director Novartis Greece \n\n\n\nHardy Rideout Anacalypsis Therapeutics \n\n\n\nGeorge Drakakis CEO PurposefulEU pharma legislation is going to change your business. What you make\, where and how you sell it\, and whether your business model is even viable.The European Commission published new legislative proposals in April that will redefine the business model of biotechnology in Europe. In trying to bring medicines to more patients\, the legislation proposals reduce data protection\, limit exclusivity for orphan medicines and brings heavy pressure to launch in all 27 Member States within two years of EMA approval.Changing the rule book that has helped build Europe’s small company ecosystem over the last 20 years is going to have consequences for start-ups\, those seeking scale up investment\, clinical trials and companies going to market\, often for the first time.This session/panel\, chaired by EuropaBio\, presents the key impacts points for biotechnology innovation within Greece\, with contributions from small and large companies and policy makers – bring your voice to the discussion for the future of your own science. \n\n\n\n\nMore information
URL:https://www.europabio.org/event/greek-biopharma-innovation-your-changing-world-with-the-new-eu-pharma-legislation/
LOCATION:Megaron Athens International Conference Centre\, Athens\, Greece
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/05/External-Events-Banners-600-×-200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20230615T080000
DTEND;TZID=Europe/Brussels:20230617T180000
DTSTAMP:20260808T003658
CREATED:20230516T094713Z
LAST-MODIFIED:20230516T104047Z
UID:6258-1686816000-1687024800@www.europabio.org
SUMMARY:3rd Hellenic Biocluster Forum
DESCRIPTION:The Hellenic BioCluster is organizing its 3rd Forum on the subject of “Supporting disruptive innovation to maximize the economic and social impact of the bio-industry sector”\, scheduled to be held between 15 – 17 June 2023 at Megaron Athens International Conference Centre\, Athens\, Greece. \n\n\n\nThe 3rd HBio Forum features a 3-day\, cutting-edge programme with inspiring speakers from across the globe\, all experts in disruptive innovation\, with the aim to connect the global biotech innovation community under the sunny Athens skies. During the Forum B2B meeting opportunities will be provided between attendees and sponsors/exhibitors. \n\n\n\nThe 3rd HBio Forum will also include targeted panels of industry experts\, mentors and life sciences professionals to discuss hot topics related to investment such as raising capital and achieving success\, followed by a Pitching Competition. \n\n\n\n\nMore Details
URL:https://www.europabio.org/event/3rd-hellenic-biocluster-forum/
LOCATION:Megaron Athens International Conference Centre\, Athens\, Greece
CATEGORIES:External
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2023/05/External-Events-Banners-2.jpg
END:VEVENT
END:VCALENDAR